[ FDA DRUG SHORTAGES TRACKER ]

A drug shortage is a quality failure with a body count.

Live FDA drug shortage data (openFDA), grouped by status, availability, and therapeutic area. The FDA’s own root-cause analysis puts manufacturing and quality problems at the centre of the shortage crisis — which is why SPEQ treats the shortage list as a quality-system signal, not just a supply-chain one.

1,000
Active shortages tracked
852
Current
147
To be discontinued
212
Flagged unavailable
21% flagged unavailable · latest update 2026-07-30 · source: openFDA drug/shortages
NEW SHORTAGES POSTED · MONTHLY

By initial FDA posting date. openFDA lists active shortages, so older cohorts thin as entries resolve.

ACTIVE SHORTAGES BY THERAPEUTIC CATEGORY · TOP 10
WHY THIS SITS UNDER QUALITY, NOT LOGISTICS

The FDA’s 2019 report Drug Shortages: Root Causes and Potential Solutions found the dominant drivers are not scarcity of raw materials but a lack of incentives to produce, and manufacturing/quality problems that force production to stop. Mature quality systems — the difference a QMM assessment measures — are what keep a line running.

The economics of quality →FDA QMM framework →
Reset
1,178 matching shortages
DrugCompanyTherapeutic areaAvailabilityStatusPosted
Allopurinol TabletTabletTeva Pharmaceuticals USA, Inc.Oncology—To Be Discontinued2026-02-19
Allopurinol TabletTabletTeva Pharmaceuticals USA, Inc.Oncology—To Be Discontinued2026-02-19
Allopurinol TabletTabletTeva Pharmaceuticals USA, Inc.Oncology—To Be Discontinued2026-02-19
Naltrexone Hydrochloride TabletTabletChartwell Molecular Holdings LLCAnalgesia/Addiction—Resolved2024-02-29
Naltrexone Hydrochloride TabletTabletAccord Healthcare Inc.Analgesia/Addiction—Resolved2024-02-29
Naltrexone Hydrochloride TabletTabletElite Laboratories, Inc.Analgesia/Addiction—Resolved2024-02-29
Naltrexone Hydrochloride TabletTabletElite Laboratories, Inc.Analgesia/Addiction—Resolved2024-02-29
Naltrexone Hydrochloride TabletTabletSpecGx LLCAnalgesia/Addiction—Resolved2024-02-29
Naltrexone Hydrochloride TabletTabletElite Laboratories, Inc.Analgesia/Addiction—Resolved2024-02-29
Naltrexone Hydrochloride TabletTabletSun Pharmaceutical Industries, Inc.Analgesia/Addiction—Resolved2024-02-29
Cefepime Hydrochloride InjectionInjectionFresenius Kabi USA, LLCAnti-Infective—To Be Discontinued2026-02-10
Chlorothiazide Oral SuspensionOral SuspensionSalix Pharmaceuticals, a division of Bausch Health US, LLCCardiovascular—To Be Discontinued2026-02-10
Cefepime Hydrochloride InjectionInjectionFresenius Kabi USA, LLCAnti-Infective—To Be Discontinued2026-02-10
Gemfibrozil TabletTabletPfizer Inc.Endocrinology/Metabolism—To Be Discontinued2026-02-10
Pindolol TabletTabletSun Pharmaceutical Industries, Inc.Cardiovascular—To Be Discontinued2026-01-30
Pindolol TabletTabletSun Pharmaceutical Industries, Inc.Cardiovascular—To Be Discontinued2026-01-30
Podofilox Topical GelTopical GelAbbVie Inc.Dermatology—To Be Discontinued2026-01-28
Fluvastatin Sodium Tablet, Extended ReleaseTabletSandoz Inc.Cardiovascular—To Be Discontinued2026-01-27
Fluvastatin Sodium Tablet, Extended ReleaseTabletSandoz Inc.Cardiovascular—To Be Discontinued2026-01-27
Benztropine Mesylate InjectionInjectionFresenius Kabi USA, LLCNeurology—To Be Discontinued2026-01-27
Methamphetamine Hydrochloride TabletTabletDr. Reddy's Laboratories, Inc.Psychiatry—Resolved2023-03-17
Methamphetamine Hydrochloride TabletTabletHikma Pharmaceuticals USA, Inc.Psychiatry—Resolved2023-03-17
Azithromycin InjectionInjectionPfizer Inc.Anti-Infective—To Be Discontinued2026-01-20
Maraviroc SolutionSolutionViiV Healthcare CompanyAntiviral—To Be Discontinued2026-01-20
Riboflavin 5-phosphate Ophthalmic SolutionOphthalmic SolutionGlaukos CorporationOphthalmology—To Be Discontinued2026-01-20
Page 42 of 48
← PrevNext →

Data: U.S. FDA openFDA drug/shortages API, which lists activeshortages (Current or To Be Discontinued) — it carries no per-record cause field, so SPEQ makes no root-cause claim on individual drugs; the quality framing above is cited FDA context. openFDA publishes shortage data for drugs only; SPEQ’s cross-industry coverage lives in the recall Explorer(drug, device & food).